Cadila Pharmaceuticals Competitors and Similar CompaniesClear all

Cadila Pharmaceuticals's competitors and similar companies include Syngene International, Biological E, UCB and Cipla.
Cadila Pharmaceuticals
Cadila Pharmaceuticals
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
Syngene International
Syngene International
Syngene International is integrated research, development, and manufacturing company providing scientific services.
Biological E
Biological E
Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date
Founding Date
1951
Founding Date
1993
Founding Date
1953
Founding Date
1928
Founding Date
1935
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Bavla, IN HQ
Akaki, ET
Dholka, IN
Chiyoda City, JP
Nairobi, KE
Moskva, RU
Ascot, GB
see more
Locations
Bangalore, IN HQ
Bangalore, IN
Bengaluru, IN
Locations
Hyderabad, IN HQ
Hyderabad, IN
Kolthur, IN
Zug, CH
Cary, US
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Employees
Employees
8,1952% increase
Employees
6,510
Employees
3,9882% increase
Employees
9,000
Employees
27,764

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
₹33.7b (FY, 2024)
Revenue (est.)
₹9.3b (FY, 2019)
Revenue (est.)
€4.9b (FY, 2023)
Revenue (est.)
₹254.5b (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
₹9.3b (FY, 2024)
Cost of goods
N/A
Cost of goods
€1b (FY, 2023)
Cost of goods
₹88.2b (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
₹25.6b (FY, 2024)
Gross profit
N/A
Gross profit
€4.8b (FY, 2023)
Gross profit
₹169.5b (FY, 2024)
Net income
Net income
N/A
Net income
₹5.1b (FY, 2024)
Net income
N/A
Net income
€343m (FY, 2023)
Net income
₹41.6b (FY, 2024)

Operating

Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
1.6 k (FY, 2019)
Suppliers
N/A
Suppliers
8.3 k (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Syngene International
HQ
Bangalore, IN
Employees
6,510

Syngene International is integrated research, development, and manufacturing company providing scientific services.

View company
Biological E
HQ
Hyderabad, IN
Employees
3,988↑ 2% increase

Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines.

View company
UCB
HQ
Brussels, BE
Employees
9,000

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company
Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company